Announcement on the Completion of Asset Transfer by Wholly-Owned Subsidiary in the Acquisition of Partial Assets of Skyline Therapeutics Limited

About this update from Xiamen Amoytop Biotech Co., Ltd. Class A

Announcement on the Completion of Asset Transfer by Wholly-Owned Subsidiary in the Acquisition of Partial Assets of Skyline Therapeutics LimitedThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Xiamen Amoytop Biotech Co., Ltd. Class A